Hematology/Oncology

Top Story

Racial, treatment-related factors may influence bevacizumab efficacy in advanced cervical cancer

Racial, treatment-related factors may influence bevacizumab efficacy in advanced cervical cancer
February 7, 2016

Use of Moore criteria may identify patients with advanced cervical cancer who may not benefit from treatment with bevacizumab, according to results of a study conducted by the Gynecologic Oncology Group.

Further, patients with moderate- or high-risk disease appeared to derive the greatest benefit from treatment with bevacizumab (Avastin, Genentech/Roche).

Children’s Research Institute at Children’s Mercy appoints chief scientific officer

February 6, 2016
Tom Curran, PhD, FRS, has been hired as chief scientific officer and executive director of Children’s Research Institute at Children’s Mercy Kansas City.The…
Meeting News Coverage

Oncologists, PCPs disagree on who should provide cancer survivorship care

February 5, 2016
Oncologists and primary care physicians within the same integrated health system disagreed on who should ultimately manage care for survivors of cancer, according to…

ABIM continues to engage physicians on MOC updates

February 5, 2016
The ABIM has announced several new efforts aimed at including internists and subspecialists in the process of improving Maintenance of Certification assessments…
In the Journals

Artificial white light as effective as daylight photodynamic therapy for actinic keratosis

February 5, 2016
Artificial white light photodynamic therapy was as effective and tolerated as daylight photodynamic therapy in men with actinic keratosis, according to study results…
More News Headlines »
CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
Video

VIDEO: David P. Ryan, MD, reviews variances between right-sided, left-sided colon cancer

January 28, 2016
More »
Featured
CME

The Patient with Pancreatic Cancer

No commercial support for this activity.

Pancreatic cancer only accounts for 3% of cancer cases, but it is the fourth leading cause of cancer-related death…
More »
Current Issues
View the Current Issue
HemOnc Today
morganatic-roan